Assessment of Capecitabine and Bevacizumab with or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial

Niharika B. Mettu, Fang Shu Ou, Tyler J. Zemla, Thorvardur R. Halfdanarson, Heinz Josef Lenz, Rimini A. Breakstone, Patrick M. Boland, Oxana V. Crysler, Christina Wu, Andrew B. Nixon, Emily Bolch, Donna Niedzwiecki, Alicia Elsing, Herbert I. Hurwitz, Marwan G. Fakih, Tanios Bekaii-Saab

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Assessment of Capecitabine and Bevacizumab with or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences